Innovent Biologics, Inc.: management transactions · Hong Kong · HKEX

Browse the full management transaction log of Innovent Biologics, Inc., a listed issuer based in Hong Kong. Shares are quoted on HK HK, under the supervision of HKEX. Operating in the Healthcare sector, Innovent Biologics, Inc. has logged 11 insider filings. Market capitalisation: €139.3bn. The latest transaction was reported on 13 May 2026 — Sale. Among the most active insiders: Ede Ronald Hao Xi. Every trade is openly available.